Catherine M. Bollard

Center for Cell and Gene Therapy, Baylor College of Medicine

Affiliated withBaylor College of Medicine

Research Area

Biography

Catherine M. Bollard has not added Biography.
If you are Catherine M. Bollard and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 26	2012

Other Publications

Article	Year
Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease. Acta haematologica\| PubMed ID: 14583674	2003
Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy. Blood\| PubMed ID: 11877273	2002
Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity. Blood\| PubMed ID: 11964281	2002
Current opinion in molecular therapeutics\| PubMed ID: 12435048	2002
Immunotherapy for Epstein-Barr virus-associated cancers in children. The oncologist\| PubMed ID: 12604735	2003
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells. Cancer gene therapy\| PubMed ID: 14685154	2004
Adoptive immunotherapy for posttransplantation viral infections. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 14993880	2004
The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 15235393	2004
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes. Blood\| PubMed ID: 15542583	2005
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. The Journal of experimental medicine\| PubMed ID: 15611290	2004
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16148164	2005
Adenoviral infections in hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 16503493	2006
Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma. Clinical lymphoma & myeloma\| PubMed ID: 16507214	2006
Immunology and cell biology\| PubMed ID: 16681825	2006
Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 16699368	2006
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leukemia & lymphoma\| PubMed ID: 16753867	2006
Adoptive immunotherapy for Hodgkin's lymphoma. International journal of hematology\| PubMed ID: 16787867	2006
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature medicine\| PubMed ID: 16998485	2006
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 17162209	2006
Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 17589291	2007
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood\| PubMed ID: 17609424	2007
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. Journal of virology\| PubMed ID: 17942545	2008
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 18463534	2008
Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 18481385	2008
Best practice & research. Clinical haematology\| PubMed ID: 18790446	2008
Leukemia & lymphoma\| PubMed ID: 18821430	2008
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 18940679	2008
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 18940685	2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients. Blood\| PubMed ID: 18971421	2009
Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 19242369	2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood\| PubMed ID: 19443656	2009
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells. Stem cells (Dayton, Ohio)\| PubMed ID: 19544439	2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood\| PubMed ID: 19700662	2009
Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU. Molecular imaging\| PubMed ID: 19728977	2009
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood\| PubMed ID: 19880495	2010
Computer-assisted quantitative evaluation of therapeutic responses for lymphoma using serial PET/CT imaging. Academic radiology\| PubMed ID: 20060747	2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after ste... Blood\| PubMed ID: 20110422	2010
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 20348004	2010
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leukemia & lymphoma\| PubMed ID: 20367572	2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience. Cytotherapy\| PubMed ID: 20429793	2010
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 20664358	2010
Blood\| PubMed ID: 20671118	2010
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood\| PubMed ID: 20709906	2010
Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood. Cytotherapy\| PubMed ID: 20818913	2010
Cytotherapy\| PubMed ID: 20942604	2010
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 20948438	2010
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 20948439	2010
Novel cord blood transplant therapies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 20951821	2011
Blood\| PubMed ID: 21310929	2011
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma. Cytotherapy\| PubMed ID: 21361747	2011
Pediatric hematology and oncology\| PubMed ID: 21381869	2011
Mediterranean journal of hematology and infectious diseases\| PubMed ID: 21416001	2009
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood\| PubMed ID: 21454450	2011
Cytotherapy\| PubMed ID: 21539497	2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. The Journal of clinical investigation\| PubMed ID: 21540550	2011
Experimental hematology\| PubMed ID: 21767511	2011
Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21908573	2011
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 21915103	2011
Aggressive peripheral CD70-positive t-cell lymphoma associated with severe chronic active EBV infection. Pediatric blood & cancer\| PubMed ID: 21994111	2011
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic h... Cytotherapy\| PubMed ID: 22172091	2012
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22226092	2012
Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2RÎ³null (NSG) mice. Experimental hematology\| PubMed ID: 22306295	2012
Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 22306904	2012
Good T cells for bad B cells. Blood\| PubMed ID: 22442331	2012
Expert review of hematology\| PubMed ID: 22475282	2012
Experimental hematology\| PubMed ID: 22507641	2012
Immunotherapy\| PubMed ID: 22512624	2012